Literature DB >> 8619426

Splenic marginal zone lymphoma. A distinct B-cell neoplasm.

R D Hammer1, A D Glick, J P Greer, R D Collins, J B Cousar.   

Abstract

The splenic marginal zone is a morphologically and perhaps immunologically distinct B-cell compartment. Lymphomas arising from cells of the splenic marginal zone are rare. Here we describe the morphologic, immunologic, and clinical features of 14 cases. Patient age ranged from 35 to 79 years (median, 68 years) with a male-to-female ratio of 1:1.8. The spleen was uniformly enlarged (median, 1,540 g; range, 388-3,845 g) in all patients, the neoplastic infiltrate had a nodular pattern in three cases, nodular and diffuse in seven cases, and diffuse in four cases. The neoplastic cells had small to medium-sized nuclei with round, oval, or slightly indented contours, small eosinophilic nucleoli, and a moderate amount of pale cytoplasm. Extrasplenic involvement was present in 12 patients. Lymph nodes often had a vaguely nodular pattern and preservation of sinuses; bone marrow was infiltrated focally (seven cases) or diffusely (one case). Five patients had hepatic involvement. Ultrastructurally, neoplastic cells differed from other small B cells and resembled normal marginal zone cells by having long, serpentine rough endoplasmic reticulum profiles. All lymphomas marked as B cells and light chain restriction was demonstrated in 12 cases. Bcl-2 protein expression was present in all cases. Most cases (70%) were negative for DBA.44 (CD72). Plasmacytic differentiation was present in three cases. In conclusion, splenic marginal zone lymphoma is a B-cell neoplasm with distinctive clinical, morphologic, immunologic, and ultrastructural characteristics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619426     DOI: 10.1097/00000478-199605000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Authors:  M Sol Mateo; M Mollejo; R Villuendas; P Algara; M Sánchez-Beato; B Martinez-Delgado; P Martínez; M A Piris
Journal:  Mol Pathol       Date:  1998-10

2.  Splenic marginal zone lymphomas of mice.

Authors:  T N Fredrickson; K Lennert; S K Chattopadhyay; H C Morse; J W Hartley
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

4.  Splenic marginal zone lymphoma: hydra with many heads?

Authors:  Luca Arcaini; Marco Paulli
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

5.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

6.  Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.

Authors:  E D Remstein; C D James; P J Kurtin
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 7.  Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis.

Authors:  Marcus Kremer; Leticia Quintanilla-Martínez; Jörg Nährig; Christoph von Schilling; Falko Fend
Journal:  Virchows Arch       Date:  2005-10-18       Impact factor: 4.064

8.  Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Authors:  Scott D Dufresne; Raymond E Felgar; Rachel L Sargent; Urvashi Surti; Susanne M Gollin; Ellen D McPhail; James R Cook; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

9.  Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.

Authors:  Minodora Onisâi; Ana-Maria Vlădăreanu; Adriana Nica; Andreea Spînu; Mihaela Găman; Horia Bumbea; Irina Voican; Iuliana Iordan; Adrian Alexandru; Mihnea Zdrenghea; Daniela Gheorghita; Sebastian Grădinaru
Journal:  Medicina (Kaunas)       Date:  2019-12-27       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.